Glaxosmi. Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE159A01016
  • NSEID: GLAXO
  • BSEID: 500660
INR
2,600.00
-38.6 (-1.46%)
BSENSE

Feb 24

BSE+NSE Vol: 16.47 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryGlaxosmi. Pharma VS Pharmaceuticals & Biotechnology
 
1D
-1.46%
-0.8%
1W
-0.14%
-0.85%
1M
12.39%
1.83%
YTD
5.11%
-2.38%
1Y
-1.45%
13.09%
3Y
98.11%
46.04%
5Y
78.94%
70.25%
10Y
61.8%
263.41%
  • Stock Absolute Returns
  • Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
4.97%
0%
4.97%
6 Months
-7.1%
0%
-7.1%
1 Year
-1.45%
0%
-1.45%
2 Years
19.77%
2.12%
21.89%
3 Years
98.11%
5.86%
103.97%
4 Years
73.3%
8.65%
81.95%
5 Years
78.94%
11.65%
90.59%

Latest dividend: 12 per share ex-dividend date: Nov-07-2024

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

2
Quartile
quartile-2
QTD
6.67%
4
Quartile
quartile-4
Sep-Dec
-7%
4
Quartile
quartile-4
Jun-Sep
-21.5%
4
Quartile
quartile-4
1Y
0.02%
2
Quartile
quartile-2
2025
9.85%
3
Quartile
quartile-3
2024
18.63%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

1
Quartile
quartile-1
QTD
6.67%
3
Quartile
quartile-3
Sep-Dec
-7%
4
Quartile
quartile-4
Jun-Sep
-21.5%
2
Quartile
quartile-2
1Y
0.02%
1
Quartile
quartile-1
2025
9.85%
3
Quartile
quartile-3
2024
18.63%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

1
Quartile
quartile-1
QTD
6.67%
4
Quartile
quartile-4
Sep-Dec
-7%
4
Quartile
quartile-4
Jun-Sep
-21.5%
3
Quartile
quartile-3
1Y
0.02%
2
Quartile
quartile-2
2025
9.85%
3
Quartile
quartile-3
2024
18.63%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available